Pharmacological heterogeneity limits antidepressant study

被引：1
作者：
Hale, AS [1 ]
机构：
[1] Univ Kent, Canterbury CT2 7NZ, Kent, England
来源：
BRITISH MEDICAL JOURNAL | 2003年 / 327卷 / 7409期
关键词：
D O I：
10.1136/bmj.327.7409.289-a
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：289 / 289
页数：1
相关论文
共 3 条
[1]  
HALE AS, 1997, DEPRESSION NEUROBIOL
[2]   PLACEBO-CONTROLLED TRIAL OF LITHIUM AUGMENTATION OF FLUOXETINE AND LOFEPRAMINE [J].
KATONA, CLE ;
ABOUSALEH, MT ;
HARRISON, DA ;
NAIRAC, BA ;
EDWARDS, DRL ;
LOCK, T ;
BURNS, RA ;
ROBERTSON, MM .
BRITISH JOURNAL OF PSYCHIATRY, 1995, 166 :80-86
[3]   Efficacy and tolerability of selective serotonin reuptake inhibitors compared with tricyclic antidepressants in depression treated in primary care: systematic review and meta-analysis [J].
MacGillivray, S ;
Arroll, B ;
Hatcher, S ;
Ogston, S ;
Reid, I ;
Sullivan, F ;
Williams, B ;
Crombie, I .
BMJ-BRITISH MEDICAL JOURNAL, 2003, 326 (7397) :1014-1017
1